companies / science-xyz
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Science Corp was listed in Khosla Ventures's portfolio, recorded 2026-09-27.
verified=2026-06-16 json
| total_raised | 490,000,000490.0M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | Alameda, United States | |
| industry | unknown | |
| stage | series-b+ |
Science Corp develops brain-computer interfaces and neural prosthetics including the PRIMA retinal implant for vision restoration. It serves patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease, plus neural researchers using the Foundry platform. The vertically integrated stack spans neural recording electronics, laser optics, and biohybrid interfaces.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-01 | series-d+ | 230,000,000230.0M | null | ○ |
| investor | src |
|---|---|
| Khosla Ventures | ○ |
astro 5.7.13, hsts, netlify, web-vitals
| fact | status | src |
|---|---|---|
| Series D+, $230.0M | attributed | ○ |
| Investor Khosla Ventures | sourced | WEB |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27provenance_investor_khosla: unknown → sourced, WEB 2026-09-27 | provenance_investor_khosla | unknown → sourced | WEB 2026-09-27 |
Records begin 2026-09-24. all_changes